Sign In
Buy BRKR
$62.70
+5.39 (+9.40%)
At Close: Jun 03, 2026
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the Stock
10:16am, Wednesday, 18'th Feb 2026
Examine the evolution of Bruker's (BRKR) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down
11:05am, Monday, 16'th Feb 2026
BRKR's Q4 EPS miss estimates as margins plunge and shares fall 2.7% despite a revenue beat, while the 2026 outlook targets 4%-5% sales growth.
These Analysts Cut Their Forecasts On Bruker Following Q4 Results
11:28am, Friday, 13'th Feb 2026
Bruker Corp (NASDAQ: BRKR) reported mixed fourth-quarter financial results on Thursday.
Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript
01:34pm, Thursday, 12'th Feb 2026
Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
11:30am, Thursday, 12'th Feb 2026
While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Bruker (BRKR) Q4 Earnings Miss Estimates
09:17am, Thursday, 12'th Feb 2026
Bruker (BRKR) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.76 per share a year ago.
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
07:00am, Thursday, 12'th Feb 2026
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025. Frank H. La
PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co
06:00pm, Wednesday, 11'th Feb 2026
Insights from the Fourth Quarter 2025 13F Filing PRIMECAP Management (Trades, Portfolio) recently submitted its 13F filing for the fourth quarter of 2025, offe
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
07:00am, Monday, 09'th Feb 2026
BOSTON--(BUSINESS WIRE)---- $BRKR #BRKR--At SLAS2026, Chemspeed Technologies, a leader in the automation and digitalization of R&D and QC laboratories, and SciY, a leader in scientific and laboratory
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation today announced the launch of iNTApharma, a label‑free characterization platform that provides single‑particle sensitivity for
Bruker Announces Quarterly Preferred Stock Dividend
04:05pm, Thursday, 05'th Feb 2026
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 05'th Feb 2026
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
08:00am, Thursday, 05'th Feb 2026
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thurs
Allspring Common Stock Fund Q4 2025 Performance Review
09:13am, Wednesday, 28'th Jan 2026
In the fourth quarter, Revolve's stock rose as its revenue met expectations with a 4.4% year-over-year increase. In fiscal second quarter 2026, Haemonetics delivered strong performance, raising guidan
Artisan Small Cap Fund Q4 2025 Portfolio Activity
09:08am, Friday, 23'rd Jan 2026
During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investme
